Medical Technology

SHERIDAN, WYOMING – May 7, 2025 – Intuitive, a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), has published two groundbreaking studies highlighting the critical role of RAS in expanding access to high-quality care. These findings emphasize how robotic-assisted procedures contribute to improving patient outcomes, especially in medical deserts, and ultimately aid the growth of minimally invasive surgery (MIS), benefiting patients globally.

SHERIDAN, WYOMING – May 7, 2025 – Intuitive, a global leader in minimally invasive care and robotic-assisted surgery, has announced that its SureForm 45 stapler has received FDA clearance for use with the da Vinci SP surgical system. The stapler is now approved for thoracic, colorectal, and urology procedures, marking a significant milestone in robotic surgical technology.

SHERIDAN, WYOMING – May 7, 2025 – Resmed Inc. (NYSE: RMD, ASX: RMD), a global leader in connected health solutions for sleep and respiratory care, has announced impressive third-quarter fiscal 2025 results. The company achieved a substantial year-over-year revenue growth of 8%, underscoring the continued demand for its innovative products and digital health solutions. With a focus on operational excellence and expanding its global footprint, Resmed has delivered a strong performance, further solidifying its position as a market leader in the healthcare sector.

SHERIDAN, WYOMING – May 7, 2025 – Hologic, Inc. (Nasdaq: HOLX) is set to showcase its latest innovations in AI-driven mammography technology at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs this week. A key highlight of the event will be the presentation of a pioneering study conducted at Massachusetts General Hospital, demonstrating the impact of Hologic's Genius AI® Detection Solution in improving breast cancer detection.

SHERIDAN, WYOMING – May 7, 2025 – Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health technologies, has unveiled its 2024 annual sustainability report, highlighting the company's robust environmental, social, and governance (ESG) initiatives. This year’s report places a strong emphasis on the company’s increased environmental commitments and its ongoing efforts to promote access and equity in women’s health.

SHERIDAN, WYOMING – May 7, 2025 – Olympus Corporation has announced key changes to its leadership structure, including the appointment of Bob White as a new Representative Executive Officer, President, and Chief Executive Officer, effective June 1, 2025. The company also revealed a change in the responsibilities of Yasuo Takeuchi, who will continue in his roles as Director, Representative Executive Officer, Executive Chairperson, and ESG Officer. These changes come as part of Olympus’s ongoing efforts to drive its transformation and growth in the global MedTech sector.

SHERIDAN, WYOMING – May 7, 2025 – Olympus Corporation, a global MedTech leader, has announced its most successful "Dress in Blue" campaign yet, marking a new milestone in its commitment to Colorectal Cancer Awareness Month. With 6,810 employees from across the globe participating, this year’s campaign underscores Olympus’ ongoing dedication to reducing cancer-related deaths through awareness and early detection initiatives.

SHERIDAN, WYOMING – May 7, 2025 – Baxter International Inc. (NYSE:BAX), a global leader in medical technologies, has announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. This dividend is payable on July 1, 2025, to shareholders of record as of May 30, 2025. The indicated annual dividend rate is set at $0.68 per share.

SHERIDAN, WYOMING – May 7, 2025 – Baxter International Inc. (NYSE: BAX), a leading global medtech company, has announced its first-quarter financial results for 2025, reflecting solid performance driven by strategic transformation initiatives. The company’s results indicate continued growth across its core business segments, positioning Baxter for long-term value creation despite global macroeconomic uncertainty.

Strategic Transformation and Focus on Execution

SHERIDAN, WYOMING – May 7, 2025 – Baxter International Inc. (NYSE: BAX), a global leader in medical technology, will host a conference call on Thursday, May 8, 2025, at 7:30 a.m. Central Time to discuss its first-quarter 2025 financial results. Investors, analysts, and other stakeholders are invited to participate in the call by pre-registering through the provided link to receive the necessary call-in information.